Samples were grouped according to DDR1 expression (low, <50% vs. high, ≥50% or low, <25% vs. high, ≥75%) and were compared to FoxP3, a nuclear transcription factor present in Tregs that represents the main tumor-promoting CD4+ T-cell population. This evidence concerns the gene DDR1 and neoplasm.